Nature.com
Nature Biotechnology, Published online: 22 July 2025; doi:10.1038/s41587-025-02752-3For decades, and in the exceptional instance of the Institut Pasteur for over a century, non-profit organizations have augmented R&D to advance scientific understanding and develop affordable and accessible pipelines of vaccines, medicines and diagnostics. Small and medium enterprises and former biopharmaceutical industry executives make a sizeable contribution to global health goals by pursuing opportunities in this corner of the global biopharmaceutical ecosystem…
Read More
Non-profits wade in where for-profit life science investment fears to tread
Barbara Nasto
17:21
Nature Biotechnology, Published online: 22 July 2025; doi:10.1038/s41587-025-02752-3For decades, and in the exceptional instance of the Institut Pasteur for over a century, non-profit organizations have augmented R&D to advance scientific understanding and develop affordable and accessible pipelines of vaccines, medicines and diagnostics. Small and medium enterprises and former biopharmaceutical industry executives make a sizeable contribution
